Since astrocytes play a major role in ALS pathology [25], and it was previously shown that BBS leads to reduction in the levels of activated astrocytes marker glial fibrillary acidic protein (GFAP), we examined the effect of BBS treatment on astrogliosis in SOD1G93A mice. Here, GFAP is linked to amyotrophic lateral sclerosis.